Autoimmune Diseases  >>  otilimab (GSK3196165)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
otilimab (GSK3196165) / GSK
NCT01023256 / 2007-006129-29: Safety and Preliminary Efficacy of MOR103 in Patients With Active Rheumatoid Arthritis

Checkmark P1b/2a trial in RA at EULAR 2015
Jun 2015 - Jun 2015: P1b/2a trial in RA at EULAR 2015
Checkmark Rheumatoid arthritis
Feb 2014 - Feb 2014: Rheumatoid arthritis
Checkmark For rheumatoid arthritis
More
Completed
1/2
96
Europe, RoW
MOR103
MorphoSys AG
Rheumatoid Arthritis
06/12
06/12
NCT01517282: Phase Ib Study to Evaluate MOR103 in Multiple Sclerosis

Checkmark For multiple sclerosis
Sep 2014 - Sep 2014: For multiple sclerosis
Completed
1/2
32
Europe
MOR103, Placebo
MorphoSys AG
Multiple Sclerosis
01/14
02/14

Download Options